SG&A at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's sg&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's SG&A?
- Charles River Laboratories (CRL) reported SG&A of $159.42M in Q1 2026.
- How has Charles River Laboratories's SG&A changed year-over-year?
- Charles River Laboratories's SG&A decreased by 10.3% year-over-year, from $177.8M to $159.42M.
- What is the long-term trend for Charles River Laboratories's SG&A?
- Over 4 years (2021 to 2025), Charles River Laboratories's SG&A has grown at a 4.6% compound annual growth rate (CAGR), from $619.92M to $743.07M.
- What does SG&A mean?
- The costs of running the business that are not directly tied to producing goods or services.
- How do you interpret SG&A?
- A decrease relative to revenue suggests improved operational efficiency, while an increase may indicate rising overhead or aggressive growth investment.
- How does SG&A compare across companies?
- Commonly benchmarked as a percentage of revenue to compare operational leverage across peers.